AAAAAA

   
Results: 1-25 | 26-43
Results: 1-25/43
PURIFICATION AND CHARACTERIZATION OF A NEW CYSTATIN INHIBITOR FROM TAIWAN COBRA (NAJA-NAJA ATRA) VENOM
Authors: BRILLARDBOURDET M NGUYEN V FERRERDIMARTINO M GAUTHIER F MOREAU T
Citation: M. Brillardbourdet et al., PURIFICATION AND CHARACTERIZATION OF A NEW CYSTATIN INHIBITOR FROM TAIWAN COBRA (NAJA-NAJA ATRA) VENOM, Biochemical journal, 331, 1998, pp. 239-244
THE INTEREST OF SURGICAL CLOSURE OF PATENT FORAMEN OVALE AFTER STROKE- A PRELIMINARY OPEN STUDY OF 8 CASES
Authors: GIROUD M TATOU E STEINMETZ E LEMESLE M COTTIN Y WOLF JE MOREAU T DAVID M
Citation: M. Giroud et al., THE INTEREST OF SURGICAL CLOSURE OF PATENT FORAMEN OVALE AFTER STROKE- A PRELIMINARY OPEN STUDY OF 8 CASES, Neurological research, 20(4), 1998, pp. 297-301
PLACEBO-CONTROLLED MULTICENTER RANDOMIZED TRIAL OF INTERFERON BETA-1BIN TREATMENT OF SECONDARY PROGRESSIVE MULTIPLE-SCLEROSIS
Authors: KAPPOS L POLMAN C POZZILLI C THOMPSON A DAHLKE F KNIGHT R HERN J COLEMAN R GERRIE L COOPER G MOORE J BORINGA J VANOOSTEN B RONNER H SCHRIJVER H TRUYEN L MONTALBAN J RIO J TINTORE M JACAS C MARZO E LECHNERSCOTT J HUBER S LIENERT C BRUNNSCHWEILER H HAWKINS S DROOGAN A MCDONNELL G DUDDY M MCKINSTRY S ALTENKIRCH H BAUM K EINHAUPL K MARX P POEWE W WALTER G AKMAN H BROCKMEIER B SCHERER P ZSCHENDERLEIN R SCHMIERER K GELDERBLOM H HARTMANN A STAPF C LUSCHOW A MACKERT B SCHUMACHER H MASUHR F HEMPEL T ZIMMERMANN R MUNCH M FRANCIS D HEAFIELD M ALMEMAR A WINER J CHONG M BROCHET B GAYOU A AURIACOMBE S DOUSSET V WILES C THOMAS F PICKERSGILL T HINDS N DAWSON K HUGHES T HUTCHINSON M MURPHY R REDMOND J WEBB S STOLL G JANDER S HAGEMANN G KOLLER H HANEMANN C KOLMEL H REICHEL D PETEREIT K THIEME A KHATAMI A NEUMANN M AMADUCCI L MASSACESI L SIRACUSA G AMATO M BARTOLOZZI L REPICE A MINDERHOUD J DEKEYSER J ZORGDRAGER A ZWANIKKEN C POSER S POLAK T GUNTHER A BITSCH A BORNER T WEBER F WIKSTROM J FARKKILA M MAJURI H SUMELAHTI M TELAKIVI T FREDRIKSON S MARTIN C MILLER D ORIORDAN J BREX P KAPOOR R WERRING D CONFAVREUX C BRUNET P HANNOUN D BRUDON F MOREAU T BLANC S DHOOGHE M JACOBS K LISSOIR F DEMONTY L COMI G COLOMBO B ROSSI P RODEGHER M SANTUCCIO G MARTINELLI F HOHLFELD R WALTHER E GOEBELS N DANG T LINDERT R VOLTZ R CARTLIDGE N BATES D MORAN G PANDIT L WESTWOOD M HALLER P SOMMER J BITTER J SUSS F MELLIES J MUCHA P LYONCAEN O DEGOS JD ROULLET E LUBETZKI C CREANGE A TOURBAH A PEZ D LECANUET P NICOLT P EDAN G BELLIARD S DEMARCO O CAHAGNE V DEBURGHGRAEVE V BRUNET I FIESCHI C MILLEFIORINI E GASPERINI C BUTTINELLI C FRONTINI M HOWELL S HADJIVASSILIOU M GIBSON A GRAHAM A HARKNESS K LAWDEN M CLANET M WAUBAN E AZAISVUILLEMIN C LAU G LOUIS C PANELIUS M RUUTIAINEN J ERALINNA J SOILUHANNINEN M GOLD R HARTUNG HP JUNG S BAYAS A FLACHENECKER P WEILBACH F ARCHELOS J KOLLEGGER H VASS K ASENBAUM S CHATSAKOS T BECKMANN K GHAZI M WAGNER K MILTENBURGER C MCFARLAND H PETKAU J SABOURAUD O TOYKA K
Citation: L. Kappos et al., PLACEBO-CONTROLLED MULTICENTER RANDOMIZED TRIAL OF INTERFERON BETA-1BIN TREATMENT OF SECONDARY PROGRESSIVE MULTIPLE-SCLEROSIS, Lancet, 352(9139), 1998, pp. 1491-1497
AZATHIOPRINE HYPERSENSITIVITY CAN STIMULA TE A WORSENING OF MYASTHENIA-GRAVIS
Authors: CHEVREL G MOREAU T VIAL T PAYEN C CONFAVREUX C
Citation: G. Chevrel et al., AZATHIOPRINE HYPERSENSITIVITY CAN STIMULA TE A WORSENING OF MYASTHENIA-GRAVIS, Therapie, 53(1), 1998, pp. 77-78
IS THE CLINICAL OUTCOME IN MULTIPLE-SCLEROSIS PREDICTABLE
Authors: CONFAVREUX C GRIMAUD J VUKUSIC S MOREAU T
Citation: C. Confavreux et al., IS THE CLINICAL OUTCOME IN MULTIPLE-SCLEROSIS PREDICTABLE, Revue neurologique, 154(8-9), 1998, pp. 624-628
RATE OF PREGNANCY-RELATED RELAPSE IN MULTIPLE-SCLEROSIS
Authors: CONFAVREUX C HUTCHINSON M HOURS MM CORTINOVISTOURNIAIRE P MOREAU T
Citation: C. Confavreux et al., RATE OF PREGNANCY-RELATED RELAPSE IN MULTIPLE-SCLEROSIS, The New England journal of medicine, 339(5), 1998, pp. 285-291
MICHELET,JULES ON WITCHCRAFT AND WOMEN
Authors: MOREAU T
Citation: T. Moreau, MICHELET,JULES ON WITCHCRAFT AND WOMEN, Europe-Revue littéraire mensuelle, 76(829), 1998, pp. 107-115
EPILEPSY IN PATIENTS WITH MULTIPLE-SCLEROSIS - RADIOLOGICAL-CLINICAL CORRELATIONS
Authors: MOREAU T SOCHURKOVA D LEMESLE M MADINIER G BILLIAR T GIROUD M DUMAS R
Citation: T. Moreau et al., EPILEPSY IN PATIENTS WITH MULTIPLE-SCLEROSIS - RADIOLOGICAL-CLINICAL CORRELATIONS, Epilepsia, 39(8), 1998, pp. 893-896
ACUTE ENCEPHALOPATHY AND IDIOPATHIC HYPEREOSINOPHILIC SYNDROME - CLINICAL AND MRI RESPONSE TO EARLY STEROID TREATMENT
Authors: MOREAU T DEREX L CONFAVREUX C
Citation: T. Moreau et al., ACUTE ENCEPHALOPATHY AND IDIOPATHIC HYPEREOSINOPHILIC SYNDROME - CLINICAL AND MRI RESPONSE TO EARLY STEROID TREATMENT, European journal of neurology, 4(6), 1997, pp. 618-621
MODELIZATION OF LONG-STAY AND HIGH COST P ATIENT DISTRIBUTION WITHIN BRONCHOPNEUMOPATHIES AND LEUKEMIA OR LYMPHOMA DIAGNOSIS RELATED GROUPS
Authors: QUANTIN C ENTEZAM F BOURDAIS C MOREAU T BRUNETLECOMTE P BOUZELAT H MATHY C FOUCHER P METRAL P DUSSERRE L
Citation: C. Quantin et al., MODELIZATION OF LONG-STAY AND HIGH COST P ATIENT DISTRIBUTION WITHIN BRONCHOPNEUMOPATHIES AND LEUKEMIA OR LYMPHOMA DIAGNOSIS RELATED GROUPS, Revue d'epidemiologie et de sante publique, 45(2), 1997, pp. 117-130
EPILEPSY REVEALING A PROLONGED QT SYNDROM E - REPLY
Authors: MOREAU T
Citation: T. Moreau, EPILEPSY REVEALING A PROLONGED QT SYNDROM E - REPLY, Revue neurologique, 153(5), 1997, pp. 359-359
NICOTINE AND MYASTHENIA-GRAVIS WORSENING
Authors: MOREAU T VUKUSIC S VANDENABEELE S CONFAVREUX C
Citation: T. Moreau et al., NICOTINE AND MYASTHENIA-GRAVIS WORSENING, Revue neurologique, 153(2), 1997, pp. 141-143
KININOGEN-DERIVED FLUOROGENIC SUBSTRATES FOR INVESTIGATING THE VASOACTIVE PROPERTIES OF RAT-TISSUE KALLIKREINS - IDENTIFICATION OF A T-KININ-RELEASING RAT KALLIKREIN
Authors: ELMOUJAHED A BRILLARDBOURDET M JULIANO MA MOREAU T CHAGAS JR GUTMAN N PRADO ES GAUTHIER F
Citation: A. Elmoujahed et al., KININOGEN-DERIVED FLUOROGENIC SUBSTRATES FOR INVESTIGATING THE VASOACTIVE PROPERTIES OF RAT-TISSUE KALLIKREINS - IDENTIFICATION OF A T-KININ-RELEASING RAT KALLIKREIN, European journal of biochemistry, 247(2), 1997, pp. 652-658
RED-CELL CATION-TRANSPORT AND PLASMA-PROTEINS IN A GENERAL URBAN MALE-POPULATION
Authors: HAJEM S MOREAU T HANNAERT P ORSSAUD G HUEL G CLAUDE JR GARAY RP LELLOUCH J
Citation: S. Hajem et al., RED-CELL CATION-TRANSPORT AND PLASMA-PROTEINS IN A GENERAL URBAN MALE-POPULATION, Cardiovascular risk factors, 6(1), 1996, pp. 50-54
UNIDIMENSIONALITY OF A FUNCTIONAL MEASURE FOR PATIENTS WITH INJURED UPPER-LIMB
Authors: LUQUET C CHAU N NADIF M GUILLEMIN F GAVILLOT C PETRY D MOREAU T BOURGKARD E HECQUET B ANDRE JM MUR JM
Citation: C. Luquet et al., UNIDIMENSIONALITY OF A FUNCTIONAL MEASURE FOR PATIENTS WITH INJURED UPPER-LIMB, Revue d'epidemiologie et de sante publique, 44(3), 1996, pp. 248-261
HOMOLOGY MODELING OF RAT KALLIKREIN RK9, A MEMBER OF THE TISSUE KALLIKREIN FAMILY - IMPLICATIONS FOR SUBSTRATE-SPECIFICITY AND INHIBITOR BINDING
Authors: MOREAU T GAUTHIER F
Citation: T. Moreau et F. Gauthier, HOMOLOGY MODELING OF RAT KALLIKREIN RK9, A MEMBER OF THE TISSUE KALLIKREIN FAMILY - IMPLICATIONS FOR SUBSTRATE-SPECIFICITY AND INHIBITOR BINDING, Protein engineering, 9(11), 1996, pp. 987-995
A PROBABILISTIC FLAW IN PGP DESIGNS
Authors: MOREAU T
Citation: T. Moreau, A PROBABILISTIC FLAW IN PGP DESIGNS, Computers & security, 15(1), 1996, pp. 39-43
COLOR-VISION LOSS AMONG STYRENE-EXPOSED WORKERS NEUROTOXICOLOGICAL THRESHOLD ASSESSMENT
Authors: CAMPAGNA D GOBBA F MERGLER D MOREAU T GALASSI C CAVALLERI A HUEL G
Citation: D. Campagna et al., COLOR-VISION LOSS AMONG STYRENE-EXPOSED WORKERS NEUROTOXICOLOGICAL THRESHOLD ASSESSMENT, Neurotoxicology, 17(2), 1996, pp. 367-373
EPILEPSY REVEALING A PROLONGED QT SYNDROM E
Authors: MOREAU T THOBOIS S COPPERE B NINET J CONFAVREUX C
Citation: T. Moreau et al., EPILEPSY REVEALING A PROLONGED QT SYNDROM E, Revue neurologique, 152(10), 1996, pp. 642-645
RISK OF CANCER FROM AZATHIOPRINE THERAPY IN MULTIPLE-SCLEROSIS - A CASE-CONTROL STUDY
Authors: CONFAVREUX C SADDIER P GRIMAUD J MOREAU T ADELEINE P AIMARD G
Citation: C. Confavreux et al., RISK OF CANCER FROM AZATHIOPRINE THERAPY IN MULTIPLE-SCLEROSIS - A CASE-CONTROL STUDY, Neurology, 46(6), 1996, pp. 1607-1612
MECHANISM OF FIRST-DOSE CYTOKINE-RELEASE SYNDROME BY CAMPATH 1-H - INVOLVEMENT OF CD16 (FC-GAMMA-RIII) AND CD11A CD18 (LFA-1) ON NK CELLS/
Authors: WING MG MOREAU T GREENWOOD J SMITH RM HALE G ISAACS J WALDMANN H LACHMANN PJ COMPSTON A
Citation: Mg. Wing et al., MECHANISM OF FIRST-DOSE CYTOKINE-RELEASE SYNDROME BY CAMPATH 1-H - INVOLVEMENT OF CD16 (FC-GAMMA-RIII) AND CD11A CD18 (LFA-1) ON NK CELLS/, The Journal of clinical investigation, 98(12), 1996, pp. 2819-2826
TRANSIENT INCREASE IN SYMPTOMS ASSOCIATED WITH CYTOKINE RELEASE IN PATIENTS WITH MULTIPLE-SCLEROSIS
Authors: MOREAU T COLES A WING M ISAACS J HALE G WALDMANN H COMPSTON A
Citation: T. Moreau et al., TRANSIENT INCREASE IN SYMPTOMS ASSOCIATED WITH CYTOKINE RELEASE IN PATIENTS WITH MULTIPLE-SCLEROSIS, Brain, 119, 1996, pp. 225-237
A REGRESSION SURVIVAL MODEL FOR TESTING THE PROPORTIONAL HAZARDS HYPOTHESIS
Authors: QUANTIN C MOREAU T ASSELAIN B MACCARIO J LELLOUCH J
Citation: C. Quantin et al., A REGRESSION SURVIVAL MODEL FOR TESTING THE PROPORTIONAL HAZARDS HYPOTHESIS, Biometrics, 52(3), 1996, pp. 874-885
ENVIRONMENTAL LEAD AND CHILDRENS INTELLIGENCE - HAIR LEAD STUDIES WERE EXCLUDED
Authors: HUEL G CAMPAGNA D MOREAU T TUBERTBITTER P
Citation: G. Huel et al., ENVIRONMENTAL LEAD AND CHILDRENS INTELLIGENCE - HAIR LEAD STUDIES WERE EXCLUDED, BMJ. British medical journal, 310(6976), 1995, pp. 397-398
PRO-RAT ATRIAL NATRIURETIC PEPTIDE-MIMICKING PEPTIDES AS SUBSTRATES FOR RAT KALLIKREINS RK2 (TONIN) AND RK9
Authors: MOREAU T BRILLARDBOURDET M CHAGAS J GAUTHIER F
Citation: T. Moreau et al., PRO-RAT ATRIAL NATRIURETIC PEPTIDE-MIMICKING PEPTIDES AS SUBSTRATES FOR RAT KALLIKREINS RK2 (TONIN) AND RK9, Biochimica et biophysica acta. Protein structure and molecular enzymology, 1249(2), 1995, pp. 168-172
Risultati: 1-25 | 26-43